The myocardium and the cardiovascular system are often involved in patients with sarcoidosis. As therapy should be started as early as possible to avoid complications such as left ventricular dysfunction, a prompt and reliable diagnosis by means of non-invasive tests would be highly warranted. Among other techniques, 18F-fuorodeoxyglucose (FDG) positron emission tomography (PET) has emerged as a high sensitive tool to detect sites of infammation before morphological changes are visible to conventional imaging techniques. We therefore aim at summarizing the most relevant fndings in the literature on the use of 18F-fuorodeoxyglucose PET in the diagnostic workup of cardiac sarcoidosis and to underline future perspectives.
The role of positron emission tomography in the assessment of cardiac sarcoidosis
Bauckneht M.;Borra A.;
2019-01-01
Abstract
The myocardium and the cardiovascular system are often involved in patients with sarcoidosis. As therapy should be started as early as possible to avoid complications such as left ventricular dysfunction, a prompt and reliable diagnosis by means of non-invasive tests would be highly warranted. Among other techniques, 18F-fuorodeoxyglucose (FDG) positron emission tomography (PET) has emerged as a high sensitive tool to detect sites of infammation before morphological changes are visible to conventional imaging techniques. We therefore aim at summarizing the most relevant fndings in the literature on the use of 18F-fuorodeoxyglucose PET in the diagnostic workup of cardiac sarcoidosis and to underline future perspectives.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
